Scalper1 News
Biotechs have dominated IBD’s industry group rankings — holding at No. 1 or No. 2 for most of the past six weeks. They develop treatments based on cellular and molecular biology to treat specific diseases such as cancer, HIV and multiple sclerosis, so there is no shortage of potential targets. But it takes years of funding, research and testing before a product comes to market. That’s where companies in IBD’s Medical-Research Equipment/Services Scalper1 News
Scalper1 News